20 LATEST RESOURCES (134 INDEXED)
Co-Prescription of Aripiprazole on Prolactin Levels in Long-Term Hospitalized Chronic Schizophrenic Patients with Co-Morbid Type 2 Diabetes: A Retrospective Clinical Study · February 2023
Articles
Frontiers in Psychiatry
Factors Influencing Prolactin Levels in Chronic Long-Term Hospitalized Schizophrenic Patients with Co-Morbid Type 2 Diabetes Mellitus · October 2022
Articles
Frontiers in Psychiatry
Antipsychotic-Related Risks of Type 2 Diabetes Mellitus in Enrollees with Schizophrenia in the National Basic Public Health Service Program in Hunan Province, China · February 2022
Articles
Frontiers in Psychiatry
Clozapine Induces Metformin-Resistant Prediabetes/Diabetes that Is Associated with Poor Clinical Efficacy in Patients with Early Treatment-Resistant Schizophrenia · August 2021
Articles
Journal of Affective Disorders
Schizophrenic Patients with Type 2 Diabetes: An 8-Year Population-Based Observational Study · March 2021
Articles
PLOS ONE
Quetiapine for the Management of Tardive Dyskinesia in Schizoaffective Disorder Comorbid with Diabetes Mellitus and Chronic Kidney Disease · February 2021
Articles
Primary Care Companion for CNS Disorders
Switching from Clozapine to Paliperidone Palmitate-3-Monthly Improved Obesity, Hyperglycemia and Dyslipidemia Lowering Antipsychotic Dose Equivalents in a Treatment-Resistant Schizophrenia Cohort · May 2020
Abstracts
International Clinical Psychopharmacology
The Relative Risk of Developing Type 2 Diabetes Mellitus in Young Adults with Schizophrenia Treated with Different Atypical Antipsychotic · February 2020
Articles
Romanian Journal of Diabetes Nutrition and Metabolic Diseases
Second-Generation Antipsychotics and Dysregulation of Glucose Metabolism: Beyond Weight Gain · October 2019
Articles
Cells
Schizoaffective Disorder Comorbid with Type 2 Diabetes Mellitus Accompanied by Frontotemporal Atrophy and Impaired Cognition: A CARE Compliant Case Report · April 2019
Articles
Medicine
Exposure to Second-Generation Antipsychotics and Risk of Type 2 Diabetes Mellitus in Adolescents and Young Adults: A Nationwide Study in Taiwan · March 2019
Articles
Journal of Clinical Psychiatry
Severe Depressive Episode with Psychotic Symptoms and Type 2 Diabetes: A 2010-2017 Longitudinal Study · March 2019
Articles
Medical Science Monitor
Comparative Risk of New-Onset Diabetes Following Commencement of Antipsychotics in New Zealand: A Population-Based Clustered Multiple Baseline Time Series Design · February 2019
Articles
BMJ Open
Evidence for Genetic Contribution to the Increased Risk of Type 2 Diabetes in Schizophrenia · November 2018
Articles
Translational Psychiatry
Combination Therapy as a Potential Risk Factor for the Development of Type 2 Diabetes in Patients with Schizophrenia: The GOMAP Study · August 2018
Articles
BMC Psychiatry
Delirium and Psychotic Symptoms Associated with Hyperglycemia in a Patient with Poorly Controlled Type 2 Diabetes Mellitus · May 2018
Articles
NCBI>Innovations in Clinical Neuroscience
Continuation of Atypical Antipsychotic Medication during Early Pregnancy and the Risk of Gestational Diabetes · May 2018
Articles
American Journal of Psychiatry
Second-Generation Antipsychotic and Diabetes Mellitus in Children and Adolescents · December 2017
Articles
La Pediatria Medica e Chirurgica
Clozapine, Diabetes Mellitus, Cardiovascular Risk and Mortality: Results of a 21-Year Naturalistic Study in Patients with Schizophrenia and Schizoaffective Disorder · November 2017
Articles (Manuscripts-Versions)
PubMed Central>Clinical Schizophrenia and Related Psychoses